FTI Consulting’s Jillian Rose Receives AICPA’s Standing Ovation Award
WASHINGTON, Nov. 16, 2018 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) is pleased to announce that Jillian Rose, a […]
Brown & Brown, Inc. Completes Acquisition of Hays Companies
DAYTONA BEACH, Fla., Nov. 16, 2018 (GLOBE NEWSWIRE) — Brown & Brown, Inc. (NYSE:BRO) today announced the completion of the […]
Imprimis Pharmaceuticals Ranked 88th Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500™
Imprimis attributes growth to its vision of making sure patients have access to high quality affordable medications SAN DIEGO, Nov. […]
Stemline Therapeutics Announces Oral Presentation of SL-701 Phase 2 Data in Second-Line Glioblastoma at the 23rd Annual Meeting of the Society of Neuro-Oncology (SNO)
NEW YORK, Nov. 16, 2018 (GLOBE NEWSWIRE) — Stemline Therapeutics, Inc. (Nasdaq: STML), a biopharmaceutical company focused on the development […]
Pacira Pharmaceuticals CMO Presents at FDA Advisory Committee Meeting Focused on Assessment of Opioid-Sparing Outcomes in Clinical Trials
PARSIPPANY, N.J., Nov. 16, 2018 (GLOBE NEWSWIRE) — Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that Chief Medical Officer Richard […]
Graph Blockchain Receives Two Patent Approvals
TORONTO, Nov. 16, 2018 (GLOBE NEWSWIRE) — Graph Blockchain Inc. (“Graph” or “Company”) (CSE: GBLC) is pleased to announce that […]
Russian Ecology Minister Tours Mechel’s Chelyabinsk Facilities
CHELYABINSK, , Nov. 16, 2018 (GLOBE NEWSWIRE) — Mechel PAO (MOEX: MTLR, NYSE: MTL), one of the leading Russian mining […]
GasLog Ltd. and GasLog Partners LP Announce Agreement to Modify Incentive Distribution Rights
Monaco, Nov. 16, 2018 (GLOBE NEWSWIRE) — GasLog Ltd. (“GasLog” or “the General Partner”) (NYSE:GLOG) and GasLog Partners LP (“GasLog […]
Staffing 360 Solutions Makes Changes to Capital Structure Designed to Return to Nasdaq Listing Requirements Compliance
NEW YORK, Nov. 16, 2018 (GLOBE NEWSWIRE) — Staffing 360 Solutions, Inc. (NASDAQ: STAF), a company executing an international buy-integrate-build […]
VBL Therapeutics Presents Results from Phase 3 GLOBE Study in Patients with Recurrent Glioblastoma at the 2018 Society for Neuro-Oncology Annual Meeting
Additional Analyses Provide Insight into Treatment Effect of VB-111 TEL AVIV, Israel, Nov. 16, 2018 (GLOBE NEWSWIRE) — VBL Therapeutics […]
